Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
[Research] SK hynix (000660 / SKHY) – Hanwha Investment & Securities | HBM Monopoly Advantage · TSMC Collaboration · Target Price Raised / 2024-06-19

[Research] SK hynix (000660 / SKHY) – Hanwha Investment & Securities | HBM Monopoly Advantage · TSMC Collaboration · Target Price Raised / 2024-06-19

RESEARCH
[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P13 SC (Zymfentra) in the U.S. (Rheumatoid Arthritis) / 2024-06-19

[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P13 SC (Zymfentra) in the U.S. (Rheumatoid Arthritis) / 2024-06-19

Disclosures
[Disclosure] Hanwha Ocean (042660) – Other Information / 2024-06-19

[Disclosure] Hanwha Ocean (042660) – Other Information / 2024-06-19

Disclosures
[Disclosure] Hana Micron (067310) – Determination of 1st Preliminary Issue Price for Capital Increase / 2024-06-18

[Disclosure] Hana Micron (067310) – Determination of 1st Preliminary Issue Price for Capital Increase / 2024-06-18

Semiconductors
[Disclosure] Hana Micron (067310) – (Correction) Decision on Capital Increase with and without Consideration / 2024-06-18

[Disclosure] Hana Micron (067310) – (Correction) Decision on Capital Increase with and without Consideration / 2024-06-18

Semiconductors
[Disclosure] Hana Micron (067310) – Ex-Rights (Capital Increase) / 2024-06-18

[Disclosure] Hana Micron (067310) – Ex-Rights (Capital Increase) / 2024-06-18

Semiconductors
[Disclosure] Hanwha Systems (272210) – Sales/Supply Contract / 2024-06-18

[Disclosure] Hanwha Systems (272210) – Sales/Supply Contract / 2024-06-18

Disclosures
[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan (Part 1) in Europe for CT-P13 SC (Pediatric Ulcerative Colitis) / 2024-06-18

[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan (Part 1) in Europe for CT-P13 SC (Pediatric Ulcerative Colitis) / 2024-06-18

Disclosures
[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan (Part 1) in Europe for CT-P13 SC (Pediatric Crohn’s Disease) / 2024-06-18

[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan (Part 1) in Europe for CT-P13 SC (Pediatric Crohn’s Disease) / 2024-06-18

Disclosures
[Disclosure] Samsung Biologics (207940) – Execution of Material Sales/Supply Contract (Correction) / 2024-06-18

[Disclosure] Samsung Biologics (207940) – Execution of Material Sales/Supply Contract (Correction) / 2024-06-18

Disclosures

Posts pagination

Previous 1 … 255 256 257 … 300 Next

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme